{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mépacrine : Questions médicales les plus fréquentes",
"headline": "Mépacrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mépacrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-23",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mépacrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aminoacridines",
"url": "https://questionsmedicales.fr/mesh/D000609",
"about": {
"@type": "MedicalCondition",
"name": "Aminoacridines",
"code": {
"@type": "MedicalCode",
"code": "D000609",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.046.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Moutarde de quinacrine",
"alternateName": "Quinacrine Mustard",
"url": "https://questionsmedicales.fr/mesh/D011797",
"about": {
"@type": "MedicalCondition",
"name": "Moutarde de quinacrine",
"code": {
"@type": "MedicalCode",
"code": "D011797",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.046.250.760.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mépacrine",
"alternateName": "Quinacrine",
"code": {
"@type": "MedicalCode",
"code": "D011796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chanakya Nath Kundu",
"url": "https://questionsmedicales.fr/author/Chanakya%20Nath%20Kundu",
"affiliation": {
"@type": "Organization",
"name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India. cnkundu@kiitbiotech.ac.in."
}
},
{
"@type": "Person",
"name": "Thomas R Lane",
"url": "https://questionsmedicales.fr/author/Thomas%20R%20Lane",
"affiliation": {
"@type": "Organization",
"name": "Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Sean Ekins",
"url": "https://questionsmedicales.fr/author/Sean%20Ekins",
"affiliation": {
"@type": "Organization",
"name": "Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA peter.madrid@sri.com sean@collaborationspharma.com."
}
},
{
"@type": "Person",
"name": "Biswajit Das",
"url": "https://questionsmedicales.fr/author/Biswajit%20Das",
"affiliation": {
"@type": "Organization",
"name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India."
}
},
{
"@type": "Person",
"name": "Chinmayee Sethy",
"url": "https://questionsmedicales.fr/author/Chinmayee%20Sethy",
"affiliation": {
"@type": "Organization",
"name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Features Linked to Treatment Outcomes in Behavioral Addictions and Related Disorders.",
"datePublished": "2023-02-07",
"url": "https://questionsmedicales.fr/article/36833569",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20042873"
}
},
{
"@type": "ScholarlyArticle",
"name": "Longitudinal associations between dispositional mindfulness and addictive behaviors in adolescents.",
"datePublished": "2023-01-01",
"url": "https://questionsmedicales.fr/article/34171109",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.20882/adicciones.1598"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of lockdown on the addictive behavior of university students in La Rioja.",
"datePublished": "2023-09-01",
"url": "https://questionsmedicales.fr/article/35472153",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.20882/adicciones.1646"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computational models of behavioral addictions: State of the art and future directions.",
"datePublished": "2022-12-22",
"url": "https://questionsmedicales.fr/article/36621045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.addbeh.2022.107595"
}
},
{
"@type": "ScholarlyArticle",
"name": "Longing to act: Bayesian inference as a framework for craving in behavioral addiction.",
"datePublished": "2023-05-13",
"url": "https://questionsmedicales.fr/article/37201396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.addbeh.2023.107752"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques 3 noyaux",
"item": "https://questionsmedicales.fr/mesh/D006575"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acridines",
"item": "https://questionsmedicales.fr/mesh/D000166"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aminoacridines",
"item": "https://questionsmedicales.fr/mesh/D000609"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mépacrine",
"item": "https://questionsmedicales.fr/mesh/D011796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mépacrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mépacrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mépacrine",
"description": "Comment diagnostiquer une infection nécessitant la mépacrine ?\nQuels tests sont utilisés pour la mépacrine ?\nLa mépacrine est-elle utilisée pour des maladies spécifiques ?\nQuels symptômes indiquent un besoin de mépacrine ?\nComment évaluer l'efficacité de la mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Behavior,+Addictive&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mépacrine",
"description": "Quels sont les effets secondaires courants de la mépacrine ?\nLa mépacrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose de mépacrine ?\nLa mépacrine affecte-t-elle le système digestif ?\nQuels signes d'infection nécessitent un traitement par mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Behavior,+Addictive&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mépacrine",
"description": "Comment prévenir les infections traitées par mépacrine ?\nLes voyages dans certaines zones augmentent-ils le risque d'infection ?\nDes vaccins existent-ils pour prévenir les infections ?\nComment réduire le risque de piqûres de moustiques ?\nLa mépacrine peut-elle être utilisée en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Behavior,+Addictive&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mépacrine",
"description": "Comment la mépacrine est-elle administrée ?\nQuelle est la posologie standard de mépacrine ?\nLa mépacrine est-elle efficace contre tous les parasites ?\nPeut-on combiner la mépacrine avec d'autres traitements ?\nQuels sont les traitements alternatifs à la mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Behavior,+Addictive&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mépacrine",
"description": "Quelles complications peuvent survenir avec la mépacrine ?\nLa mépacrine peut-elle causer des problèmes hématologiques ?\nQuels signes indiquent une complication grave ?\nComment gérer les complications liées à la mépacrine ?\nLes complications sont-elles fréquentes avec la mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Behavior,+Addictive&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mépacrine",
"description": "Quels facteurs augmentent le risque d'infection ?\nL'âge influence-t-il le risque d'effets secondaires ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe influence-t-il la réponse à la mépacrine ?\nLes interactions médicamenteuses sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Behavior,+Addictive&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection nécessitant la mépacrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de laboratoire pour identifier les parasites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la mépacrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de selles peuvent être effectués."
}
},
{
"@type": "Question",
"name": "La mépacrine est-elle utilisée pour des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour traiter la leishmaniose et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de mépacrine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, des douleurs abdominales et des éruptions cutanées peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de la mépacrine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction des symptômes et des résultats de tests de suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de la mépacrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des nausées, des vomissements et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La mépacrine peut-elle provoquer des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques comme des démangeaisons ou un gonflement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose de mépacrine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de surdose incluent des vertiges, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "La mépacrine affecte-t-elle le système digestif ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des troubles digestifs comme des douleurs abdominales et des diarrhées."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection nécessitent un traitement par mépacrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs abdominales sévères et de la fièvre persistante peuvent nécessiter un traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections traitées par mépacrine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des mesures d'hygiène, l'utilisation de moustiquaires et des vaccins."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones augmentent-ils le risque d'infection ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infections parasitaires."
}
},
{
"@type": "Question",
"name": "Des vaccins existent-ils pour prévenir les infections ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins sont disponibles pour certaines infections, mais pas pour toutes."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de piqûres de moustiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des répulsifs, porter des vêtements longs et installer des moustiquaires."
}
},
{
"@type": "Question",
"name": "La mépacrine peut-elle être utilisée en prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle n'est généralement pas utilisée en prévention, mais plutôt en traitement actif."
}
},
{
"@type": "Question",
"name": "Comment la mépacrine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mépacrine est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de mépacrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie selon l'infection, mais elle est souvent de 100 à 200 mg par jour."
}
},
{
"@type": "Question",
"name": "La mépacrine est-elle efficace contre tous les parasites ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est principalement efficace contre certains parasites comme ceux de la leishmaniose."
}
},
{
"@type": "Question",
"name": "Peut-on combiner la mépacrine avec d'autres traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être combinée avec d'autres médicaments selon la maladie traitée."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs à la mépacrine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des alternatives incluent l'antimoniate de méglumine et d'autres antiparasitaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la mépacrine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles hépatiques et des réactions cutanées sévères."
}
},
{
"@type": "Question",
"name": "La mépacrine peut-elle causer des problèmes hématologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles sanguins comme l'anémie ou la thrombocytopénie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des saignements inhabituels ou des douleurs abdominales sévères doivent alerter."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à la mépacrine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'arrêt du médicament et un suivi médical approprié."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec la mépacrine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un système immunitaire affaibli, des voyages dans des zones à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'effets secondaires ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de la mépacrine."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies hépatiques ou sanguines augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il la réponse à la mépacrine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le sexe peut influencer la pharmacocinétique de la mépacrine."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent augmenter les effets secondaires ou réduire l'efficacité."
}
}
]
}
]
}
Behavioral addictions are incompletely understood with respect to their underlying etiologies. This incomplete understanding may contribute to the frequent relapse and dropout rate often observed with...
Adolescence is a vulnerable period for the development of addictive behaviors, and substance use (SU) and problematic Internet use (PIU) typically start during this developmental stage. Dispositional ...
One of the consequences of the COVID-19 health crisis was the general lockdown. Research shows that lockdown situations may cause changes in addictive behaviors. The objective of the present study was...
Non-pharmacological behavioral addictions, such as pathological gambling, videogaming, social networking, or internet use, are becoming major public health concerns. It is not yet clear how behavioral...
Traditionally, craving is considered a defining feature of drug addiction. Accumulating evidence suggests that craving can also exist in behavioral addictions (e.g., gambling disorder) without drug-in...
Two recent papers in the Journal of Behavioral Addictions by Brand et al. (2022), and Sassover and Weinstein (2022) both make interesting additions to the place of behavioral addictions in the more ge...
The endogenous cannabinoid system is involved in several physiological functions in the central nervous system including the modulation of brain reward circuitry and emotional homeostasis. Substantial...
The authors began with an initial search for review articles to assist in the identification of relevant literature. This was followed by separate searches for primary literature and recent studies. T...
The initial search yielded a total of 49 review articles on PubMed, 13 on ScienceDirect, and 17 on Wiley Online, from which the authors garnered information from a total of 16 reviews. In addition to ...
The review discusses the effects of alcohol consumption on brain endocannabinoid signaling, including alcohol-based perturbations in endocannabinoid-mediated synaptic transmission, the modulation of a...
Translational research on addictive behaviors viewed as molar behavioral allocation is critically reviewed. This work relates rates of behavior to rates of reinforcement over time and has been fruitfu...
Narrative critical review....
This approach distinguishes between final and efficient causes of discrete behaviors. The former refers to temporally extended behavior patterns into which the act fits. The latter refers to environme...
Although efficient cause analysis has dominated translational research, research supports viewing addictive behavior as molar behavioral allocation. Increasing concern with rate variables underpinning...
While many studies have examined the relationship between problematic social media use (PSMU) and mental health disorders, little is known about reward responsiveness mechanisms that might be driving ...
Recently, we were deeply saddened by the findings of the coroner investigating the death of 14-year-old Molly Russell. Deeply saddened and angry but not surprised. This case should be seen as a sentin...